New jersey

Index
Globenewswire

Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate

Globenewswire

Synchronoss Meraih Sertifikasi Kerangka Privasi Data UE-A.S.

Globenewswire

Synchronoss Achieves EU-U.S. Data Privacy Framework Certification

Globenewswire

KLOG Transport Solutions Delivers Cargo Visibility Across Europe Powered by ORBCOMM® Satellite IoT Technology

Globenewswire

Spring Bio Solution Meluncurkan NCE Grid untuk Mendekode Peluang Pengajuan Para IV dan First-to-File

Globenewswire

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities

Globenewswire

ORBCOMM® Launches CrewView to Enable Smart Containers to Fill the Last Gap in End-to-end Visibility While at Sea

Globenewswire

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025

Globenewswire

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with T

Globenewswire

Verisk Welcomes Christopher Perry and Sabra Purtill to its Board of Directors

Globenewswire

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)

Globenewswire

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Globenewswire

Verisk Unveils First-of-Its-Kind SRCC Catastrophe Model for the U.S. to Quantify Political Violence Risks

Globenewswire

Trigyn Technologies Appoints Vikram Chandna as Chief Executive Officer

Globenewswire

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

Globenewswire

Teva and Samsung Bioepis Announce Biosimilar EPYSQLI® (eculizumab-aagh) Injection Now Available in the United States

Globenewswire

Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention

Globenewswire

New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable

Globenewswire

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

Globenewswire

UPDATE -- RAM Photonics Industrial Launches Mass Production of 2D Fiber Arrays for AI and DC

Globenewswire

Verisk Nominates Christopher Perry and Sabra Purtill to the Company’s Board of Directors

Globenewswire

Folk Maritime Becomes Middle East’s First Dry Container Fleet to Deploy ORBCOMM®’s Smart Container Technology

Globenewswire

Vanotech Appoints Matthew Schiller to Lead Business Development

Globenewswire

ORBCOMM® Announces OGx Enhancements to Improve Satellite IoT Accessibility

Globenewswire

Synchronoss Memperkenalkan Capsyl Cloud di MWC Barcelona – Solusi Cloud Pribadi Turn-Key untuk Operator Global